Both the present investigation examining PC cells and our previous studies using prostate cancer and colon cancer cells (13) also demonstrated that NDRG1 expression inhibited β-catenin phosphorylation at Ser552 promoting its transcriptional activity (46). The gene discussed is NDRG1; the disease is prostate cancer.